SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Sonny Liston — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientSonny Liston
Date of birth1932-05-08
IdentifiersMRN HR-BX007-SYN-TD; SSN (made up) 000-07-8853
Document date1969-06-23
AuthorMalcolm Achebe-Whitford, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Two-week review of high blood pressure, seen the same day by cardiology. [S]

History of Present Illness

Sonny Liston returns two weeks after intake and is seen the same day by Dr. Lindqvist-Owusu. He wore the ambulatory blood pressure monitor for 24 hours last week, including a training session, and had an echocardiogram this morning. His intake blood tests were normal apart from a mildly raised AST and GGT, which were explained to him in plain words as signs that alcohol is affecting his liver. He has cut his drinking from about 25 drinks a week to about 18 by keeping a tally of marks on a card, but found the weekends hard. He feels well and has no headaches, chest pain, breathlessness or palpitations. He wants to know whether he can fight again this year. No thoughts of suicide. [S]

ElementDetail
Ambulatory monitoringDaytime 146/94, nighttime 132/84, 24-hour 142/91 mmHg
EchocardiogramMild concentric LVH (12 mm); ejection fraction 60 percent; normal diastolic function
DrinkingAbout 18 drinks a week, from about 25
Urine albumin18 mg/g, normal

Review of Systems

SystemResultFinding
CardiovascularNegativeNo chest pain, palpitations, fainting or ankle swelling
RespiratoryNegativeNo breathlessness beyond what he expects in hard sparring
NeurologicalNegativeNo headaches, vision change or weakness
PsychiatricNegativeMood all right; no thoughts of suicide

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Amlodipine 5 mg and valsartan 160 mg combined oral tablet, one tablet each morningOne tablet each morningOral route1969-06-23 to 1969-07-21completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1969-06-23Body height185cmS
1969-06-23Body weight98.6kgS
1969-06-23Body mass index (BMI) [Ratio]28.8kg/m2S
1969-06-23Systolic blood pressure148mm[Hg]S
1969-06-23Diastolic blood pressure96mm[Hg]S
1969-06-23Heart rate56/minS
1969-06-23Respiratory rate14/minS
1969-06-23Body temperature36.6CelS
1969-06-23Oxygen saturation in Arterial blood by Pulse oximetry99%S

Physical Exam

Vital signs recorded on 1969-06-23; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 148/96 mmHg (average of two, large cuff); pulse 56; weight 98.6 kg
CardiovascularRegular slow rhythm; no murmur, gallop or edema; foot pulses normal
RespiratoryClear to auscultation

Problems

ProblemClinical statusVerificationCodeProvenance
High blood pressure readings at a first visit (154/98 mmHg, average of two readings with a large cuff), without a diagnosis of hypertension; out-of-office confirmation neededresolvedconfirmed R03.0S — Synthetic presenting finding; resolved into the diagnosis at the consultation visit when ambulatory monitoring confirmed hypertension.
Hypertension, stage 2, confirmed by 24-hour ambulatory monitoring (daytime average 146/94 mmHg, nighttime 132/84 mmHg), with mild concentric left ventricular hypertrophy on echocardiography and normal kidney function and urine albuminactiveconfirmed I10S — Synthetic modern diagnosis; no hypertension is documented in his life.
Alcohol use disorder, moderate (four DSM-5-TR criteria: drinking more than intended, unsuccessful efforts to cut down, craving, and continued drinking despite its effect on his training, blood pressure and liver tests); AUDIT 16activeconfirmed F10.20S — Synthetic modern diagnosis by interview, anchored to the description of heavy drinking; not a historical diagnosis.
Personal history of physical abuse in childhood (beaten regularly by his father), with heavy field work from the age of eightactiveconfirmed Z62.810S — Synthetic coding of the documented childhood history; physical abuse only.
Does not read or write (no schooling as a child); prefers spoken explanations, pictures and demonstrationsactiveconfirmed Z55.0S — Synthetic coding of the documented literacy, recorded so that care is adapted.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationOffice blood pressure (seated, large cuff, average of two readings), weight and BMI, heart soundsEvery visitCompleted today148/96 mmHg; weight 98.6 kg; no gallop
ExaminationOut-of-office blood pressure (ambulatory or home monitoring)At diagnosis and after each treatment changeCompleted today24-hour ambulatory monitoring last week: daytime 146/94, nighttime 132/84 mmHg; confirms hypertension
LaboratoryPotassium, creatinine and eGFRBaseline; two to four weeks after starting an ARB; then every six months on an ARBOrderedBaseline potassium 4.1 mmol/L and creatinine 1.1 mg/dL (eGFR 89) at intake; recheck at four weeks after starting valsartan
LaboratoryLipids, glucose or A1c, urine albumin-to-creatinine ratio, TSHAt diagnosis, then yearly (TSH at diagnosis)Up to dateAt intake: LDL 122, HDL 58 mg/dL; A1c 5.4%; urine albumin-to-creatinine ratio 18 mg/g; TSH 1.6
Imaging12-lead ECGBaseline at diagnosisUp to dateAt intake: sinus bradycardia 56; LVH voltage criteria without repolarization change
ImagingEchocardiogramAt diagnosis for stage 2 hypertension or suspected LVH; repeat as indicatedCompleted todayMild concentric LVH (12 mm); ejection fraction 60 percent; normal diastolic function and aortic root
ExaminationFundoscopic examinationYearlyDueAt the preventive visit
SurveyCardiovascular risk estimateYearlyDueAt the preventive visit; the pooled cohort equations apply only from 40
Medication safetyAntihypertensive tolerance (ankle edema, dizziness) and adherence by teach-backEach follow-up and each dose changeNot indicatedNo antihypertensive until today; teach-back of the new tablet done with the picture card
ReferralFitness to compete (AHA/ACC athlete statement)At diagnosis and before returning to competitionCompleted todayCardiology: no competition until controlled; then clearance with a repeat check
SurveyDrinking (AUDIT-C, drinks per week, drinking days)Every follow-up during treatment; full AUDIT at about four monthsUp to dateAUDIT 16 at intake; about 18 drinks a week now by his tally; next AUDIT-C at four weeks
LaboratoryLiver tests (AST, ALT, GGT)Baseline; about two months after starting naltrexone or cutting down; then as indicatedUp to dateAt intake: AST 46, ALT 38, GGT 88 U/L; recheck in about two months
SurveySuicide-risk review (structured questions) and safety planEvery visitCompleted todayNo thoughts of suicide; safety plan card reviewed
Self-managementHealth literacy: teach-back, picture card, read-aloud consent, voice remindersEvery visitCompleted todayPlan explained in two key points; he repeated them back correctly; consent for the echocardiogram read aloud

Goal progress:

Guideline basis: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); Hypertension in Adults: Screening (2021); CMID: Clinical Monitoring Intelligence Database, hypertension and depression monographs (2026); Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 6: Hypertension (Black HR, et al.) (2015); The Healthcare Professional's Core Resource on Alcohol (2026); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); AHRQ Health Literacy Universal Precautions Toolkit, 3rd Edition (2024)

Follow-up: Four-week review with potassium, creatinine and AUDIT-C. Home readings each morning by photo message. Call 988 or the clinic at any time if thoughts of suicide arise. Next scheduled visit 1969-07-21: four-week review: blood pressure on treatment, potassium and creatinine, drinking, and medicine teach-back. [S]